ENTERA BIO LTD. (ENTX) Total liabilities 2020–2025
ENTERA BIO LTD. (ENTX) total liabilities at each fiscal year-end, per SEC filings.
$2.9MFY2025 · since FY2020: $2.2M → $2.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.9M | +120.8% |
| FY2024 | $1.3M | -5.0% |
| FY2023 | $1.4M | +0.4% |
| FY2022 | $1.4M | -59.9% |
| FY2021 | $3.4M | +54.7% |
| FY2020 | $2.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENTX financial trends
ENTX RevenueENTX Net incomeENTX Net marginENTX Gross profitENTX Gross marginENTX Operating incomeENTX Operating marginENTX Operating cash flowENTX Free cash flowENTX Capital expendituresENTX Return on equityENTX Stock buybacksENTX Dividends paidENTX Total assetsENTX Shareholders’ equityENTX overview →